Cargando…
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers
Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or severe disease was related to the antibody levels after vaccination or infection, with lower protection aga...
Autores principales: | Shachor-Meyouhas, Yael, Dabaja-Younis, Halima, Magid, Avi, Leiba, Ronit, Szwarcwort-Cohen, Moran, Almog, Ronit, Mekel, Michal, Weissman, Avi, Hyams, Gila, Gepstein, Vardit, Horowitz, Nethanel A., Cohen Saban, Hagar, Tarabeia, Jalal, Halberthal, Michael, Hussein, Khetam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958857/ https://www.ncbi.nlm.nih.gov/pubmed/36851161 http://dx.doi.org/10.3390/vaccines11020283 |
Ejemplares similares
-
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
por: Hussein, Khetam, et al.
Publicado: (2022) -
Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2022) -
COVID-19: Healthcare Workers May Be at Greater Risk Outside Their Work Environment—A Retrospective Observational Study
por: Hussein, Khetam, et al.
Publicado: (2022) -
Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2021) -
Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses
por: Braun, Eyal, et al.
Publicado: (2022)